Gaviscon

Indigestion, Heartburn, Urinary Bladder + 4 more
Treatment
9 FDA approvals
20 Active Studies for Gaviscon

What is Gaviscon

Magnesium carbonateThe Generic name of this drug
Treatment SummaryAlginic acid, also known as algin or alginate, is a type of polysaccharide extracted from certain seaweed species. It forms a thick, viscous gel when mixed with water. Alginic acid is made up of molecules of L-glucuronic acid and D-mannuronic acid and is used in a variety of products, including food, cosmetics, and pharmaceuticals. It is approved by the FDA as an emulsifier, thickener, and stabilizer in soups and soup mixes. It is also found in antacids to help reduce gastric acid reflux, and
Inonis the brand name
image of different drug pills on a surface
Gaviscon Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Inon
Magnesium carbonate
1989
2

Approved as Treatment by the FDA

Magnesium carbonate, also known as Inon, is approved by the FDA for 9 uses like Heartburn and Kidney Stones .
Heartburn
Kidney Stones
Used to treat Kidney Stones in combination with Citric acid
Indigestion
Irrigation
Used to treat catheter irrigation in combination with Citric acid
Irrigation
Used to treat catheter irrigation therapy in combination with Citric acid
Upset stomach
Kidney Stones
Used to treat Kidney Stones in combination with Citric acid
Heartburn
Urinary Bladder
Used to treat Calculus bladder in combination with Citric acid

Effectiveness

How Gaviscon Affects PatientsAlginic acid works to reduce stomach acid reflux by forming a physical barrier. This barrier, called a "raft", is formed when the acid meets the alginic acid, usually within a few seconds of taking it. In clinical trials, alginic acid has been shown to reduce GERD symptoms. It has also been shown to reduce postprandial reflux when taken with an antacid. Alginic acid binds to cations when consumed.
How Gaviscon works in the bodyWhen swallowed, alginic acid reacts with stomach acid to create a foam-like barrier on the surface of the stomach contents. This barrier helps prevent stomach acid from refluxing back up into the esophagus, which can reduce pain and discomfort. In severe cases, the foam itself can be refluxed, providing a soothing effect.

When to interrupt dosage

The measure of Gaviscon is contingent upon the diagnosed condition, including Hiatus Hernia, Dyspepsia and Gastroesophageal Reflux Disease (GERD). The dosage can be found in the table below, contingent on the approach to delivery.
Condition
Dosage
Administration
Kidney Stones
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Irrigation
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Irrigation
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Heartburn
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Indigestion
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Urinary Bladder
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral
Upset stomach
, 105.0 mg, 50.0 mg/mL, 35.8 mg/mL, 0.058 mg/mg, 0.4 mg/mg, 0.59 mg/mg, 115.0 mg, 32.0 mg, 52.3 mg, 232.0 mg, 52.32 mg, 100.0 mg, 172.2 mg, 34.0 mg, 80.0 mg, 32.68 mg/mL, 33.76 mg/mL, 237.5 mg/mL, 40.0 mg, 200.0 mg, 300.0 mg, 4.2 mg, 125.0 mg, 100.0 units, 120.0 mg, 125.0 mg/mL, 100.0 mg/mL, 0.0152 mg/mg, 0.05 mg/mg, 34.22 mg, 13.4 mg/mL, 25.0 mg, 0.2 mg/mg, 0.15 mg/mg, 0.07 mg/mg, 0.03442 mg/mg, 13.5 mg, 160.0 mg, 75.0 mg
Tablet, chewable, , Oral, Tablet, chewable - Oral, Suspension - Oral, Suspension, Liquid - Oral, Liquid, Capsule - Oral, Powder - Oral, Capsule, Powder, Granule - Oral, Granule, Tablet, film coated - Oral, Tablet, film coated, Tablet, Tablet - Oral, Solution, Irrigation, Solution - Irrigation, Granule, effervescent, Granule, effervescent - Oral

Warnings

Gaviscon Contraindications
Condition
Risk Level
Notes
Urinary Tract Infections
Do Not Combine
urinary tract extravasation
Do Not Combine
There are 20 known major drug interactions with Gaviscon.
Common Gaviscon Drug Interactions
Drug Name
Risk Level
Description
2,5-Dimethoxy-4-ethylamphetamine
Major
The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be increased when it is combined with Magnesium carbonate.
2,5-Dimethoxy-4-ethylthioamphetamine
Major
The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be increased when it is combined with Magnesium carbonate.
4-Bromo-2,5-dimethoxyamphetamine
Major
The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be increased when it is combined with Magnesium carbonate.
Amphetamine/Dextroamphetamine
Major
The serum concentration of Amphetamine can be increased when it is combined with Magnesium carbonate.
Atazanavir
Major
Magnesium carbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gaviscon Toxicity & Overdose RiskTaking more than 15g/kg of this drug can be lethal for humans. Symptoms of overdosing on this drug may include abdominal bloating, intestinal blockage, nausea, vomiting, and difficulty swallowing. Inhaling or swallowing this drug can cause lung inflammation. If someone has overdosed on this drug, they should receive medical treatment.
image of a doctor in a lab doing drug, clinical research

Gaviscon Novel Uses: Which Conditions Have a Clinical Trial Featuring Gaviscon?

88 active studies are looking into the possibility of utilizing Gaviscon for Flatulence, Hiatus Hernia and Reflux Esophagitis (RE) treatment.
Condition
Clinical Trials
Trial Phases
Irrigation
0 Actively Recruiting
Upset stomach
0 Actively Recruiting
Urinary Bladder
0 Actively Recruiting
Kidney Stones
32 Actively Recruiting
Not Applicable, Early Phase 1, Phase 2
Indigestion
6 Actively Recruiting
Phase 3, Not Applicable, Phase 2
Irrigation
0 Actively Recruiting
Heartburn
2 Actively Recruiting
Phase 3, Not Applicable

Gaviscon Reviews: What are patients saying about Gaviscon?

5Patient Review
7/26/2022
Gaviscon for Condition in which Stomach Acid is Pushed Into the Esophagus
I love this medicine, it's a life saver. I've been using it since it was released at 80 rs, but now the company has become so greedy and increased prices every few months... Now the price is increased again to 164 rs. Stop being greedy!
5Patient Review
8/16/2022
Gaviscon for Stomach Ulcer
This has been an extremely effective way for me to control my stomach acid. I was initially hesitant because it's available over-the-counter, but this really does work well.
5Patient Review
2/28/2022
Gaviscon for Condition in which Stomach Acid is Pushed Into the Esophagus
This treatment is really effective and it only took 2-3 minutes to start working.
5Patient Review
5/31/2017
Gaviscon for Heartburn
I was diagnosed with GERD/Acid Reflux in 2010 and prescribed Pantoloc 40mg. This medication did not work for me; I would cough all night and have to sleep upright for 1-3 hours before finally falling asleep. In early 2016, a good EENT doctor recommended Gaviscon Extra and it has controlled my acid reflux 100%. I am so grateful and thankful to that doctor!
5Patient Review
1/7/2017
Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux
I've been using Gaviscon for three months to treat my gastritis, and it's been working great in conjunction with an acid inhibitor. However, I recently noticed that my silver necklace has started tarnishing. Could the medication be causing this?
5Patient Review
4/16/2015
Gaviscon for Ulcer from Stomach Acid
It is effective. I'm wondering if I should take it before or after my cardiac medication, though.
5Patient Review
12/4/2021
Gaviscon for Conditions of Excess Stomach Acid Secretion
I've been struggling with some intense acid reflux as of late. Thankfully, my doctor recommended Gaviscon to help ease the pain. And it really does work wonders! I noticed a difference within just three or four minutes after taking it.
5Patient Review
9/6/2022
Gaviscon for Heartburn
These heartburn relief tablets work almost instantaneously, which always shocks me. They're definitely a lifesaver.
5Patient Review
3/25/2014
Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux
5Patient Review
4/19/2014
Gaviscon for Conditions of Excess Stomach Acid Secretion
5Patient Review
8/31/2022
Gaviscon for Indigestion
I don't think a more effective drug exists anywhere. It gave me instant relief.
4.7Patient Review
6/22/2020
Gaviscon for Conditions of Excess Stomach Acid Secretion
I use this product whenever I'm bloated, and it works like a charm every single time.
4.3Patient Review
2/20/2022
Gaviscon for Heartburn
This medication is really effective for me, and I only need a small amount. It numbs my mouth and cools everything down, which is a huge relief when I'm dealing with bad heartburn.
4Patient Review
5/17/2020
Gaviscon for Heartburn
Gavison is great for when I get heartburn. It's quickly relieved me about 90% of the time, and within 15 minutes at that! If I'm still in pain after half an hour, I'll take another 1/2 tablet. As a side note, East Indian cuisine really gives me some bad acid reflux!
3.3Patient Review
5/27/2014
Gaviscon for Stomach Ulcer
This drug is good, but you have to take it every day. I had breathing problems and pain at night due to acid in my esophagus, but now that I'm taking this medication regularly, those symptoms have gone away.
1Patient Review
6/10/2022
Gaviscon for Hiatal Hernia with Esophagus Inflammation from Acid Reflux
This treatment did not improve my symptoms and, if anything, made them worse.
1Patient Review
9/12/2022
Gaviscon for Heartburn
Gaviscon infant is prescribed for children under the age of four, so this review is irrelevant.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about gaviscon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Gaviscon safer than omeprazole?

"There was no significant difference between groups in pain intensity reduction, although overall qualitative pain relief was slightly (p = 0.049) in favor of omeprazole. Results of the GOOD trial also showed that Gaviscon and omeprazole 20 mg could be used both safely."

Answered by AI

What is Gaviscon used for?

"Gaviscon can be used to treat heartburn (acid reflux) and indigestion by forming a protective layer that floats on top of the contents of your stomach and stops stomach acid from escaping into your food pipe."

Answered by AI

Should you drink water with Gaviscon?

"You should chew the chewable tablets thoroughly before swallowing, and then drink a full glass of water. If you are using the liquid form of this medication, shake the bottle well before each dose, and refrigerate it to improve the flavor. Do not freeze."

Answered by AI

Is Gaviscon the best antacid?

"Gaviscon Double Action Liquid was more effective than an antacid without alginate in reducing stomach acid exposure after a meal. However, the number and distribution of reflux events within the esophagus were similar."

Answered by AI

Clinical Trials for Gaviscon

Image of United States, Alabama University of Alabama at Birmingham in Birmingham, United States.

Oxalate Synthesis for Kidney Stones

18 - 80
All Sexes
Birmingham, AL
The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test
Recruiting
Has No Placebo
United States, Alabama University of Alabama at Birmingham (+1 Sites)Sonia Fargue, PhD
Image of University of Iowa in Iowa City, United States.

Genetic Testing for Kidney Stones

18 - 90
All Sexes
Iowa City, IA
Kidney stones continue to affect more and more people in the United States with the most recent estimate being 1 in 9 people will develop a stone in their life. While family history is a known risk factor for stone disease, it remains unclear whether this is related to learned dietary habits or a truly inheritable genetic condition. Known inheritable genetic conditions linked to stone formation are uncommon, and thus, routine genetic testing is not currently recommended by any major urologic organizations. Patients who form calcium phosphate predominant stones, a less common type of stone composition, tend to have alkaline urine pH which suggests that the kidneys are unable to rid the body of acid. Management of such patients for stone prevention can be difficult. The Iowa Institute for Human Genomics is one of only a handful of commercial labs which offers genetic testing for stone disease. The aim of this study is to assess the rate of genetic abnormalities amongst calcium phosphate predominant stone formers with alkaline urine. To this end, the investigators plan to enroll calcium phosphate predominant stone forming patients with alkaline urine on 24 hour urine collection who obtain their health care at UIHC to undergo free genetic testing via blood draw to assess for genetic abnormalities. The investigators will also collect information already available in the subject's chart to assess for other patterns between blood and urine tests and any genetic variants.
Recruiting
Has No Placebo
University of Iowa
Have you considered Gaviscon clinical trials? We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.Go to Trials
Image of Mayo Clinic in Rochester in Rochester, United States.

High Resolution Gastric Mapping and Gastroduodenal Manometry for Indigestion

18 - 80
All Sexes
Rochester, MN
Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensation. Therapeutic options manage symptoms, and there is no FDA approved medical therapy for dyspepsia. There is a need for better objective understanding of sensorimotor dysfunction in dyspepsia, as well as noninvasive, efficacious, safe, and inexpensive treatments for dyspepsia. The purpose of this research is to identify disturbances and characterize phenotypes in patients with functional dyspepsia, and to assess the correlations between symptoms (during the manometry and in daily life), gastric emptying, electrical activity (BSGM), and pressure activity (manometry).
Recruiting
Has No Placebo
Mayo Clinic in RochesterNicholas R Oblizajek, MD
Image of Children's Hospital of Philadelphia in Philadelphia, United States.

Meditation for Recovery After Kidney Stone Surgery

Any Age
All Sexes
Philadelphia, PA
The goal of this pilot clinical trial is to learn whether meditation can help improve recovery in children and adults having surgery for kidney stones. The main questions it aims to answer are: * Does meditation around the time of surgery improve pain and anxiety in patients undergoing kidney stone surgery (ureteroscopy)? * Is a meditation program around the time of surgery feasible for patients having kidney stone surgery (ureteroscopy)? Participants will be randomly assigned to the meditation group and the control group to understand how meditation affects recovery after surgery. Participants will be asked to: * Complete a health history form * Complete questionnaires about pain and mood before surgery and certain days after surgery * Those in the meditation group will learn and practice a daily 20-minute meditation for 2-4 weeks before surgery and 2 weeks after surgery * Those in the meditation group will be asked to provide feedback of the meditation program after completing the last questionnaire
Waitlist Available
Has No Placebo
Children's Hospital of Philadelphia (+1 Sites)Gregory E Tasian, MD
Image of The University of Chicago Medical Center in Chicago, United States.

Bupivacaine for Kidney Stones

18+
All Sexes
Chicago, IL
Post-operative pain and lower urinary tract symptoms are common following ureteroscopy in the treatment of stone disease. The use of bupivacaine as a topical pain medication is used routinely for other urologic procedures, however, to date there are no studies that have rigorously investigated the effect of instilling bupivacaine in the bladder following ureteroscopy. This is a randomized study that will investigate the effect of instilling bupivacaine in the bladder following routine ureteroscopy, laser lithotripsy and ureteral stenting in the treatment of stone disease. Compared to a placebo of Normal Saline, our study hypothesizes that administration of topical bupivacaine in the bladder will decrease post-operative pain and lower urinary tract symptoms while improving quality of life in the early post-operative period.
Phase 2
Recruiting
The University of Chicago Medical CenterLuke Reynolds, MD
Have you considered Gaviscon clinical trials? We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.Go to Trials
Image of Northwestern Medicine in Chicago, United States.

Laser Lithotripsy for Kidney Stones

18 - 90
All Sexes
Chicago, IL
The purpose of this study is to compare Moses 2.0 pulse modulation technology and the standard high powered Holmium Laser lithotripsy and how it will affect time in the operating room, time using the laser, laser energy, and stone free rates. Currently Moses 2.0 laser technology is FDA approved and currently used in practice since 2021. No study to this date has compared Moses 2.0 without pulse modulation laser technology to Moses 2.0 with pulse modulation laser technology. The study will be including kidney and ureteral stones (a kidney stone located in the tube between the kidney and the bladder) that are 6mm and greater, but less than 20 mm in size undergoing ureteroscopic treatment. High powered lasers are used for "dusting". Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.
Recruiting
Has No Placebo
Northwestern MedicineAmy Krambeck, MD
Image of University of Alabama at Birmingham in Birmingham, United States.

Diet and Oxalate Absorption for Kidney Stones

18 - 70
All Sexes
Birmingham, AL
The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased absorption of dietary oxalate, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will * ingest fixed diets containing low and moderately high amounts of oxalate for 5 days at a time * ingest a soluble form of oxalate and sugar preparations to test gut permeability * collect urine, blood, stool and breath sample during the fixed diets and the soluble oxalate test
Recruiting
Has No Placebo
University of Alabama at Birmingham (+1 Sites)Sonia Fargue, PhD
Have you considered Gaviscon clinical trials? We made a collection of clinical trials featuring Gaviscon, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security